On April 16, 2026, a Federal Circuit panel in Teva Pharms. Int'l GmbH v. Eli Lilly & Company, No. 24-1094, held that patent claims directed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results